Bartus, 1982, Science, 217, 408, 10.1126/science.7046051
Candy, 1986, Prog Brain Res, 70, 105, 10.1016/S0079-6123(08)64300-9
Court, 1991, Pharmacol Ther, 52, 423, 10.1016/0163-7258(91)90035-K
Court, 1993, Brain Res Dev Brain Res, 74, 73, 10.1016/0165-3806(93)90085-O
Davis, 1999, JAMA, 281, 1401, 10.1001/jama.281.15.1401
1994. Cholinergic systems and related neuropathological predilection patterns in Alzheimer disease. In Alzheimer Disease, (eds). Raven Press: New York; 263-291.
Giacobini, 1990, Prog Brain Res, 84, 321, 10.1016/S0079-6123(08)60916-4
Giacobini, 1998, J Physiol Paris, 92, 283, 10.1016/S0928-4257(98)80034-X
2000. Cholinesterase inhibitors: from the Calabar bean to Alzheimer therapy. In Cholinesterase and Cholinesterase Inhibitors, (ed.). Martin Donitz: London; 181-226.
Giacobini, 1989, Prog Brain Res, 79, 335, 10.1016/S0079-6123(08)62493-0
Giacobini, 2002, J Neural Transm, 109, 1053, 10.1007/s007020200089
Herholtz, 2000, J Neural Transm, 107, 1457, 10.1007/s007020070009
Inglis, 2002, Int J Clin Pract, 127, 45
Kuhl, 1999, Neurology, 52, 691, 10.1212/WNL.52.4.691
2000. Neuroanatomy of cholinesterases in the normal human brain and in Alzheimer's disease. In Cholinesterase and Cholinesterase Inhibitors, (ed.). Martin Donitz: London; 121-137.
Mori, 1995, Neuroreport, 6, 633, 10.1097/00001756-199503000-00012
2001. Brain functional imaging in early and preclinical Alzheimer's disease. In Alzheimer Disease: Advances in Etiology, Pathogenesis and Therapeutics, (eds). John Wiley & Sons Ltd: Chichester; 153-164.
Perry, 1980, Age Ageing, 9, 1, 10.1093/ageing/9.1.1
Rosler, 2002, Int J Clin Pract, 127, 20
Tiraboschi, 2000, Neurology, 54, 407, 10.1212/WNL.54.2.407
Turrini, 2001, Neuroscience, 105, 277, 10.1016/S0306-4522(01)00172-5
